Redecol is a medical device company focussed on the development of an asthma monitoring device to address the need for a new type of lung function test which exists within the monitoring sector of asthma management.

 

Redecol is using patented sensor technology to develop a unique asthma monitoring tool which does not require a forced breathing technique.

Redecol employs a core team with a wealth of experience in the medical device industry. This team is supported by a strong network of consultants and agencies to provide the highest possible quality of skills and knowledge required to develop a world class medical device.

 
 

Board of Directors

 
About us template.png
 

Graham Hine
Chairman of the Board

Graham has recently been appointed as Chairman of Redecol.  Graham has a broad experience of Chairman and CEO roles across a range of medical equipment, nanotechnology and sensor companies, including listed and VC backed entities.

 
Tim-01.jpg
 

Tim Coutts
CEO

Tim has recently been appointed as CEO to Redecol. Tim brings over 20 years' experience in the medtech industry from multinational companies, such as Boston Scientific to SMEs and is a former board member of ABHI.

 
Zia.jpg
 

Zia Mursaleen
Finance Director

Zia is a chartered accountant and corporate financier having qualified and worked with Deloitte for 10 years. He is a founder of VA Corporate Finance Ltd providing corporate finance and financial consultancy to SMEs for over 20 years.

 
 
 
 

Andy Moss
Market Development and Access Director

Andy has recently lead the market development and access process for Redecol. Andy has considerable pharmaceutical and medical device experience, particularly with regard to market development, market access and in building specialist Sales & Marketing teams to deliver these strategies.

 
About us template.png
 

Barbara Lead
Non-Exec Director

With a wealth of experience in the asthma space, Barbara is the CEO of Oval Medical, which was recently acquired by SMC, becoming the first successful exit for Syndicate Room.

 
 
 
 

The Redecol Team

 
 

Tim Coutts
CEO

Tim has recently been appointed as CEO to Redecol. Tim brings over 20 years' experience in the medtech industry from multinational companies, such as Boston Scientific to SMEs and is a former board member of ABHI.

 
Zia.jpg
 

Zia Mursaleen
Finance Director

Zia is a chartered accountant and corporate financier having qualified and worked with Deloitte for 10 years. He is a founder of VA Corporate Finance Ltd providing corporate finance and financial consultancy to SMEs for over 20 years.

 
About us template.png
 

Andy Moss
Market Development and Access Director

Andy has recently lead the market development and access process for Redecol. Andy has considerable pharmaceutical and medical device experience, particularly with regard to market development, market access and in building specialist Sales & Marketing teams to deliver these strategies.

 
 
Lee-01.jpg
 

Lee Brooks
R&D Manager

Previously employed at Anaxsys, Lee has developed the sensor technology at the heart of the Breathe Easy Flow Device. Following completion of his PhD, he has been instrumental in developing the production and testing of sensors for clinical and commercial use.

 
About us template.png
 

Margaret McQueen
QA Manager

Margaret joined Redecol from Sanofi with nearly 20' years' experience in the research and development of asthma products. Her clincal manufacturing experience supports the regulatory and quality system for Redecol.

 
 

Mark Wade
Supply Chain and QA Support

Mark brings a wealth of knowledge in sourcing and supplier management from over 30 years' experience in the pharmaceutical industry, initiated at Fisons.